Literature DB >> 23122528

Quantitative Heel Ultrasound (QUS) measures of bone quality in association with mood and anxiety disorders.

Lana J Williams1, Julie A Pasco, Felice N Jacka, Jason M Hodge, Mark A Kotowicz, Michael Berk.   

Abstract

BACKGROUND: The common mental disorders are potential risk factors for low bone mass as a result of disease and/or medication-related processes. Quantitative heel ultrasound (QUS) is a portable and relatively cheap screening tool for determining fracture risk. Thus, we investigated the association between QUS parameters, mood and anxiety disorders in a population-based sample of 745 men and 897 women.
METHODS: Using a clinical interview (SCID-I/NP), mood and anxiety disorders were identified. Bone quality was established using QUS and included the following parameters: Broadband Ultrasound Attenuation (BUA), Speed of Sound (SOS) and Stiffness Index (SI). Anthropometry, socio-economic status (SES), medication use and lifestyle factors were determined.
RESULTS: In men, mood and anxiety disorders were associated with lower age-weight- and smoking-adjusted SOS, BUA and SI. In women, age was an effect modifier. Among younger women (≤ 40yr), mood disorders were associated with lower age-weight- and smoking-adjusted SOS and SI but not BUA. No differences were detected in older women or women with anxiety disorders. These patterns persisted after adjustment for activity, alcohol, calcium intake, SES and medications. LIMITATIONS: Cross-sectional study design, and possible residual or unrecognised confounding.
CONCLUSION: Our data suggest that bone quality, as measured by QUS, is reduced among men and younger women with a history of mood disorders. Furthermore, an inverse association between anxiety disorders and bone quality was evident for men. Thus, QUS may be a useful screening tool for determining fracture risk within these populations.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23122528     DOI: 10.1016/j.jad.2012.09.025

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  A GABAergic neural circuit in the ventromedial hypothalamus mediates chronic stress-induced bone loss.

Authors:  Fan Yang; Yunhui Liu; Shanping Chen; Zhongquan Dai; Dazhi Yang; Dashuang Gao; Jie Shao; Yuyao Wang; Ting Wang; Zhijian Zhang; Lu Zhang; William W Lu; Yinghui Li; Liping Wang
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 2.  Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression.

Authors:  Brisa S Fernandes; Jason M Hodge; Julie A Pasco; Michael Berk; Lana J Williams
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

3.  Anxiety disorders and age-related changes in physiology.

Authors:  Julian Mutz; Thole H Hoppen; Chiara Fabbri; Cathryn M Lewis
Journal:  Br J Psychiatry       Date:  2022-09       Impact factor: 10.671

4.  Body composition and bone mineral status in patients with Turner syndrome.

Authors:  Kun Shi; Li Liu; Yao-Juan He; Duan Li; Lian-Xiong Yuan; Gendie E Lash; Li Li
Journal:  Sci Rep       Date:  2016-11-30       Impact factor: 4.379

5.  The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.

Authors:  P H Rauma; J A Pasco; M Berk; A L Stuart; H Koivumaa-Honkanen; R J Honkanen; J M Hodge; L J Williams
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

Review 6.  Bone-Derived Modulators That Regulate Brain Function: Emerging Therapeutic Targets for Neurological Disorders.

Authors:  Hongzhen Chen; Dewei Shang; Yuguan Wen; Chao Liang
Journal:  Front Cell Dev Biol       Date:  2021-06-10

7.  Lifetime depression and age-related changes in body composition, cardiovascular function, grip strength and lung function: sex-specific analyses in the UK Biobank.

Authors:  Julian Mutz; Cathryn M Lewis
Journal:  Aging (Albany NY)       Date:  2021-07-07       Impact factor: 5.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.